A Big Year for New HIV Prevention Choices

Craig W. Hendrix, MD
Wellcome Professor and Director, Division of Clinical Pharmacology
Departments of Medicine and Pharmacology
Johns Hopkins University School of Medicine, Baltimore, MD

Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2020. All rights reserved.



VIDEOTop of page

About the Presenter:Top of page

Craig Hendrix trained in infectious diseases and clinical pharmacology at Hopkins before 10 years as an Air Force physician and 23 years at Johns Hopkins. Dr. Hendrix’s primary research focus is clinical pharmacology of HIV pre-exposure prophylaxis. He’s served as Principal Investigator of over 75 phase I clinical studies, mostly involving pre-exposure prophylaxis at Hopkins. He’s also served as principal pharmacologist for over 50 clinical trials in the Microbicide Trials Network and HIV Prevention Trials Network. He has published over 250 original scientific papers.

Learning Objectives: Top of page

At the completion of this educational session, learners will:

  • Describe the challenges to PrEP development.
  • Describe the challenges to PrEP implementation.
  • Discuss ongoing development of vaginal and rectal microbicides.
  • Discuss ongoing development of long-acting PrEP, including antiretrovirals and monoclonal antibodies.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from: Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

You must be logged in to post a comment. Login | Register